Source 1primary paper2026MED
Toolkit/MRT-5005
MRT-5005
Also known as: MRT5005
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
We critically analyze lessons learned from clinical trial failures, including ALN-RSV01 and MRT-5005, to identify key barriers to successful translation.
Usefulness & Problems
Why this is useful
MRT-5005 is presented in the abstract as a named clinical RNA therapeutic example discussed for lessons from trial failure in pulmonary delivery.; clinical case study of pulmonary RNA therapeutic translation
Source:
MRT-5005 is presented in the abstract as a named clinical RNA therapeutic example discussed for lessons from trial failure in pulmonary delivery.
Source:
clinical case study of pulmonary RNA therapeutic translation
Problem solved
In the context of this review, it helps identify key barriers to successful translation of lung-targeted RNA therapeutics.; used as an example to identify barriers to successful translation in lung RNA delivery
Source:
In the context of this review, it helps identify key barriers to successful translation of lung-targeted RNA therapeutics.
Source:
used as an example to identify barriers to successful translation in lung RNA delivery
Problem links
used as an example to identify barriers to successful translation in lung RNA delivery
LiteratureIn the context of this review, it helps identify key barriers to successful translation of lung-targeted RNA therapeutics.
Source:
In the context of this review, it helps identify key barriers to successful translation of lung-targeted RNA therapeutics.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Mechanisms
Translation ControlTechniques
No technique tags yet.
Target processes
translationImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: externally suppliedimplementation constraint: context specific validationoperating role: delivery
Operational role: delivery. Implementation mode: externally supplied. Cofactor status: cofactor requirement unknown.
The abstract associates it with clinical trial failure, so it is not presented here as a successful solution to pulmonary RNA delivery.; described in the abstract as part of clinical trial failures
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
ALN-RSV01 is discussed as a clinical trial failure case that informs barriers to successful translation in lung-targeted RNA delivery.
MRT-5005 is discussed as a clinical trial failure case that informs barriers to successful translation in lung-targeted RNA delivery.
Approval Evidence
1 source1 linked approval claimfirst-pass slug mrt-5005
We critically analyze lessons learned from clinical trial failures, including ALN-RSV01 and MRT-5005, to identify key barriers to successful translation.
Source:
negative translational signalsupports
MRT-5005 is discussed as a clinical trial failure case that informs barriers to successful translation in lung-targeted RNA delivery.
Source:
Comparisons
Source-stated alternatives
The abstract mentions ALN-RSV01 alongside MRT-5005 as another clinical comparator.
Source:
The abstract mentions ALN-RSV01 alongside MRT-5005 as another clinical comparator.
Source-backed strengths
provides a concrete clinical failure-analysis example
Source:
provides a concrete clinical failure-analysis example
Compared with ALN-RSV01
The abstract mentions ALN-RSV01 alongside MRT-5005 as another clinical comparator.
Shared frame: source-stated alternative in extracted literature
Strengths here: provides a concrete clinical failure-analysis example.
Relative tradeoffs: described in the abstract as part of clinical trial failures.
Source:
The abstract mentions ALN-RSV01 alongside MRT-5005 as another clinical comparator.
Ranked Citations
- 1.